Aeovian Pharmaceuticals Company

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Technology: NeuroTech
Industry: Biopharma, Biotechnology, Health Care, Pharmaceutical
Headquarters: San Francisco, California, United States
Founded Date: 2012
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 37000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2019
Last Funding Type: Series A

Visit Website
Register and Claim Ownership